Status:
UNKNOWN
Influence of the Design of the Transmucosal Abutment on the Periimplant Bone Level
Lead Sponsor:
University of Santiago de Compostela
Collaborating Sponsors:
Mozo Grau Ticare Implants
Conditions:
Peri-implant Marginal Bone Loss
Peri-implant Bone Level
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the radiographic changes on the marginal peri-implant bone level on bone level implants with a narrower transmucosal abutment, in comparison to the conventio...
Detailed Description
Patients will receive from one to eight bone-level implants according to their rehabilitation necessity and transmucosal abutments will be connected the day of the surgery. The control group will rece...
Eligibility Criteria
Inclusion
- Absence of systemic and periodontal pathology, over 18 years of age, with a plaque index below 25%.
- Absence of at least one tooth, with natural adjacent teeth, allowing a prosthetic rehabilitation with an osseointegrated implant and a prosthetic unit.
- Adequate bone quality available, allowing placement of MOZO GRAU® implants InHex STD QUATTRO with diameters of 3.75 mm or 4.25 mm and lengths of 8, 10 and 11.5 mm.
- Natural teeth or implants with fixed restoration as antagonists.
Exclusion
- Systemic factors:
- Continuous administration of systemic medication that can interfere with the bone metabolism or medical conditions requiring prolonged use of steroids and / or medications that can interfere with bone metabolism.
- History of leukocyte dysfunction and deficiency, immunodeficiency syndromes, kidney failure or bone metabolic disorders, such as osteoporosis.
- Physical disability that may interfere with proper oral hygiene.
- Use of any investigational medication or device within the previous 30 days to implant surgery in the study.
- Alcoholism or drug addiction
- Smoker of more than 10 cigarettes per day.
- Conditions or circumstances that could prevent compliance with participation in study or interfere with the analysis of results, such as a history of breach or unreliability.
- Local factors:
- History of local radiotherapy.
- Bruxism.
- Diseases that affect the oral mucosa, such as oral lichen planus.
- Untreated periodontitis.
- Persistent intraoral infection.
- Post-extraction alveoli not cured (less than 6 weeks after extraction).
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04385355
Start Date
October 1 2024
End Date
November 1 2024
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Santiago de Compostela
Santiago de Compostela, La Coruña, Spain, 15782